Salicylamide

Salicylamide

SCHEMBL28057428

NC(=O)c1ccccc1O.O=C(O)c1ccccc1OCc1ccccc1O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.59
KMT2A Q03164 3/20 0.56
MEN1 O00255 1/20 0.56
KDM4E B2RXH2 4/20 0.54
HTT P42858 2/20 0.54
HPGD P15428 3/20 0.53
HSD17B10 Q99714 2/20 0.53
MAPT P10636 1/20 0.53
TSHR P16473 1/20 0.53
TP53 P04637 1/20 0.52
PARP1 P09874 2/20 0.49
AKR1C1 Q04828 1/20 0.48
PTK2B Q14289 1/20 0.48
MCL1 Q07820 2/20 0.47
FOLH1 Q04609 2/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
HMGB1 P09429 1/20 0.46
CA4 P22748 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Salicylic Acid SCHEMBL30476656 0.91 ALDH1A1 (0.66) ALDH1A1KMT2AMEN1KDM4EHTT
Salicylic Acid SCHEMBL31052931 0.91 ALDH1A1 (0.66) ALDH1A1KMT2AMEN1KDM4EHTT
SCHEMBL38459 0.91 ALDH1A1 (0.69) ALDH1A1KMT2AMEN1KDM4EHTT
SCHEMBL27320205 0.90 ALDH1A1 (0.68) ALDH1A1KMT2AMEN1KDM4EHTT
SCHEMBL27344933 0.90 ALDH1A1 (0.68) ALDH1A1KMT2AMEN1KDM4EHTT
Salicylic Acid SCHEMBL3879225 0.86 ALDH1A1 (0.59) ALDH1A1KMT2AMEN1KDM4EHTT
SCHEMBL14879637 0.84 HTT (0.68) ALDH1A1KMT2AMEN1KDM4EHTT
SCHEMBL2467710 0.83 KDM4E (0.66) ALDH1A1KMT2AKDM4EHTTHPGD
SCHEMBL27914372 0.80 ALDH1A1 (0.56) ALDH1A1KMT2AMEN1KDM4EHTT
SCHEMBL14735475 0.78 ALDH1A1 (0.52) ALDH1A1KMT2AMEN1HTTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105764501-A Compositions for improving the therapeutic benefit of bisantrene 现代化制药公司 2016-07-13 CN disclosed
CN-105764502-A Combination methods for improving the therapeutic benefit of bisantrene and analogs and derivatives thereof 现代化制药公司 2016-07-13 CN disclosed